Contents: Issue 1

• Welcome From Paul Merrick, Chair of the Pharmaceuticals Technical Activity Committee
• Industry News
• A New Approach to Validation - Is this the end to the validation ‘V’ model?
• EMEA to Update GMP Guide With Starting Materials Section

Download a PDF version of this newsletter

• View other issues

---

 
[November 2007] AstraZeneca is to invest $120 million in a new Process Research and Development (PR&D) Laboratory at its Macclesfield site, Cheshire, adding to the company’s significant investment in the UK over recent years. 

• Ortho Clinical Diagnostics is a subsidiary of Johnson and Johnson is building a new pilot plant for Diagnostic kits and materials at its Whitchurch facility near Cardiff. The cost of this project is believed to be around £16M Target date for completion is Q1 2008. 

• Cancer Research UK is building a new Biotechnology pilot plant at its site in South Mimms north of London. The project is estimated to be worth £10M and is expected to be completed at the end of 2009.